Last $14.89 USD
Change Today -0.15 / -1.00%
Volume 743.9K
AMRI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas E. D'Ambra Ph.D.

Co-Founder and Non-Executive Chairman, Albany Molecular Research Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 2 different organizations across 3 different industries.

See Board Relationships
58$4,043,140
As of Fiscal Year 2013

Background*

Dr. Thomas E. D'Ambra, also known as Tom, Ph.D. co-founded Albany Molecular Research Inc. in 1991 and served as its Chief Executive Officer from 1991 to December 31, 2013. Dr. D'Ambra served as the President at Albany Molecular Research Inc. since February 2003. He served as the President of Molecular Research Inc., from 1991 to 1998. He co founded Coromed Inc., and served as its Vice President of Chemistry from 1989 to 1991. He served as Group Leader and Senior Research ...

Read Full Background

Corporate Headquarters*

26 Corporate Circle
Albany, New York 12212

United States

Phone: 518-512-2000
Fax: 518-512-2020

Board Members Memberships*

Director
1991-Present
Co-Founder and Non-Executive Chairman

Education*

PhD
Massachusetts Institute of Technology
BA
College of the Holy Cross

Other Affiliations*

Annual Compensation*

Salary$478,462
Total Annual Compensation$478,462

Stock Options*

Restricted Stock Awards$159,729
All Other Compensation$2,948,099
Exercisable Options20,000
Exercisable Options Value$143,000
Unexercisable Options180,000
Unexercisable Options Value$949,400
Total Value of Options$1,092,400
Total Number of Options200,000

Total Compensation*

Total Annual Cash Compensation$3,653,811
Total Short Term Compensation$478,462
Other Long Term Compensation$3,107,828
Total Calculated Compensation$4,043,140
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRI:US $14.89 USD -0.15

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Steven M. Klosk Chief Executive Officer, President and Director
Cambrex Corporation.
$533.3K
Masayo Tada Chief Executive Officer, President, Representative Director and Chairman of Risk Management Committee
Sumitomo Dainippon Pharma Co., Ltd.
--
Rudolf Hanko Ph.D.Chief Executive Officer and Chief Executive Officer of Siegfried Group
Siegfried Holding AG
SFr.647.9K
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Justin Korteasa Interim Managing Director
GlaxoSmithKline Consumer Nigeria Plc
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALBANY MOLECULAR RESEARCH, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.